Min Zhang
Changzhi University(CN)Jiangsu University(CN)Tongji University(CN)Tianjin Agricultural University(CN)Central South University(CN)Nanchang University(CN)Sun Yat-sen University(CN)Henan University of Science and Technology(CN)Duke University(US)Capital Medical University(CN)Zhaoqing University(CN)Anhui Medical University(CN)Changzhi Medical College(CN)Duke Energy (United States)(US)Third Affiliated Hospital of Southern Medical University(CN)First Affiliated Hospital of Jiangxi Medical College(CN)Shandong Provincial Hospital(CN)Beijing Anzhen Hospital(CN)First Affiliated Hospital of Xi'an Jiaotong University(CN)Duke Medical Center(US)The First Affiliated Hospital, Sun Yat-sen University(CN)People's Hospital of Shiyan(CN)Shanghai Tenth People's Hospital(CN)Henan Provincial People's Hospital(CN)First Affiliated Hospital of Anhui Medical University(CN)Liupanshui Normal University(CN)Southern Medical University Shenzhen Hospital(CN)Affiliated Zhongshan Hospital of Dalian University(CN)Ministry of Agriculture and Rural Affairs(CN)Duke University Hospital(US)Shandong First Medical University(CN)First Hospital of Xi'an(CN)First Affiliated Hospital of Nanchang University(CN)Shanghai Ocean University(CN)Southern Medical University(CN)Nanjing Medical University(CN)Tsinghua University(CN)
Publications by Year
Research Areas
Extracellular vesicles in disease, Mesenchymal stem cell research, Organ Transplantation Techniques and Outcomes, Sperm and Testicular Function, MicroRNA in disease regulation
Most-Cited Works
- → SphK1 and SphK2, Sphingosine Kinase Isoenzymes with Opposing Functions in Sphingolipid Metabolism(2005)627 cited
- → Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms(2004)226 cited
- → Survivin mediates resistance to antiandrogen therapy in prostate cancer(2005)218 cited
- → Sirt1 Activation Ameliorates Renal Fibrosis by Inhibiting the TGF‐β/Smad3 Pathway(2013)198 cited
- → Characterization of Nestin-positive stem Leydig cells as a potential source for the treatment of testicular Leydig cell dysfunction(2014)191 cited
- → NNC 55-0396 [(1 S,2 S)-2-(2-(N-[(3-Benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]: A New Selective Inhibitor of T-Type Calcium Channels(2004)169 cited